Sensing viral invasion by RIG-I like receptors

Current Opinion in Microbiology

Volumn 20, Issue , 2014, Pages 131-138

  Yoo, Ji Seung ^a   Kato, Hiroki ^a   Fujita, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOUBLE STRANDED RNA; INTERFERON; LABORATORY OF GENETICS AND PHYSIOLOGY 2 RNA HELICASE; MDA5 RNA HELICASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; RECEPTOR; RETINOIC ACID INDUCIBLE GENE 1 LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE L; RNA HELICASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS RNA; DEAD BOX PROTEIN; IMMUNOGLOBULIN RECEPTOR;

CELL SURVIVAL; COXSACKIE VIRUS; CYTOKINE PRODUCTION; CYTOPLASM; DENGUE VIRUS; ENCEPHALITIS VIRUS; ENCEPHALOMYOCARDITIS VIRUS; ENTEROVIRUS; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HOMEOSTASIS; IMMUNE EVASION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INNATE IMMUNITY; JAPANESE ENCEPHALITIS VIRUS; LA CROSSE VIRUS; MEASLES VIRUS; MENGO VIRUS; MOLECULAR RECOGNITION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NOROVIRUS; PARECHOVIRUS; PROTEIN PROCESSING; RABIES VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RIFT VALLEY FEVER BUNYAVIRUS; RNA SEQUENCE; RNA STRUCTURE; SEMLIKI FOREST ALPHAVIRUS; SENDAI VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRAL INVASION; VIRAL PHENOMENA AND FUNCTIONS; VIRUS GENOME; VIRUS INFECTION; WEST NILE FLAVIVIRUS; ANIMAL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MAMMAL; METABOLISM; SECRETION (PROCESS); VIRUS;

ANIMALS; CYTOKINES; DEAD-BOX RNA HELICASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MAMMALS; RECEPTORS, IMMUNOLOGIC; RNA, VIRAL; VIRUSES;

EID: 84902951706     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.05.011     Document Type: Review

References (67)

1. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
2. Chen G., Shaw M.H., Kim Y.G., Nunez G. Nod-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 2009, 4:365-398.
3. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale M., Akira S., Yonehara S., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005, 175:2851-2858.
4. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., Tsujimura T., Fujita T., Akira S., Takeuchi O. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2010, 107:1512-1517.
5. Takahasi K., Yoneyama M., Nishihori T., Hirai R., Kumeta H., Narita R., Gale M., Inagaki F., Fujita T. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008, 29:428-440.
6. Jiang F., Ramanathan A., Miller M.T., Tang G.Q., Gale M., Patel S.S., Marcotrigiano J. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 479:423-427.
7. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
8. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009, 21:317-337.
9. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
10. Onoguchi K., Onomoto K., Takamatsu S., Jogi M., Takemura A., Morimoto S., Julkunen I., Namiki H., Yoneyama M., Fujita T. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 2010, 6:e1001012.
11. Chiang H.S., Zhao Y., Song J.H., Liu S., Wang N., Terhorst C., Sharpe A.H., Basavappa M., Jeffrey K.L., Reinecker H.C. GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses. Nat Immunol 2014, 15:63-71.
12. Habjan M., Hubel P., Lacerda L., Benda C., Holze C., Eberl C.H., Mann A., Kindler E., Gil-Cruz C., Ziebuhr J., Thiel V., et al. Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. PLoS Pathog 2013, 9:e1003663.
13. Hyde J.L., Gardner C.L., Kimura T., White J.P., Liu G., Trobaugh D.W., Huang C., Tonelli M., Paessler S., Takeda K., Klimstra W.B., et al. A viral RNA structural element alters host recognition of nonself RNA. Science 2014, 343:783-787.
14. Kim D.H., Longo M., Han Y., Lundberg P., Cantin E., Rossi J.J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 2004, 22:321-325.
15. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., et al. 5'-triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
16. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
17. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., Reis e Sousa C. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
18. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., Coch C., Janke M., Mihailovic A., Wardle G., Juranek S., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
19. Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., Wenzel M., Hoffmann F.S., Michallet M.C., Besch R., Hopfner K.P., Endres S., et al. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106:12067-12072.
20. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 2010, 107:16303-16308.
21. Panda D., Dinh P.X., Beura L.K., Pattnaik A.K. Induction of interferon and interferon signaling pathways by replication of defective interfering particle RNA in cells constitutively expressing vesicular stomatitis virus replication proteins. J Virol 2010, 84:4826-4831.
22. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
23. Marques J.T., Devosse T., Wang D., Zamanian-Daryoush M., Serbinowski P., Hartmann R., Fujita T., Behlke M.A., Williams B.R. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 2006, 24:559-565.
24. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-i and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
25. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
26. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10:1065-1072.
27. Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
28. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
29. Malathi K., Saito T., Crochet N., Barton D.J., Gale M., Silverman R.H. RNase l releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 2010, 16:2108-2119.
30. McCartney S.A., Thackray L.B., Gitlin L., Gilfillan S., Virgin H.W., Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog 2008, 4:e1000108.
31. Schulz O., Pichlmair A., Rehwinkel J., Rogers N.C., Scheuner D., Kato H., Takeuchi O., Akira S., Kaufman R.J., Reis e Sousa C. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 2010, 7:354-361.
32. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82:335-345.
33. Feng Q., Hato S.V., Langereis M.A., Zoll J., Virgen-Slane R., Peisley A., Hur S., Semler B.L., van Rij R.P., van Kuppeveld F.J. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep 2012, 2:1187-1196.
34. Pichlmair A., Schulz O., Tan C.P., Rehwinkel J., Kato H., Takeuchi O., Akira S., Way M., Schiavo G., Reis e Sousa C. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 83:10761-10769.
35. Luthra P., Sun D., Silverman R.H., He B. Activation of IFN-β expression by a viral mRNA through RNase L and MDA5. Proc Natl Acad Sci U S A 2011, 108:2118-2123.
36. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., Yamamoto M., Akira S., Fitzgerald K.A. The RNA helicase LGP2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-i. J Immunol 2005, 175:5260-5268.
37. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., Saijo S., Iwakura Y., Barber G.N. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007, 178:6444-6455.
38. Ouda R., Onomoto K., Takahasi K., Edwards M.R., Kato H., Yoneyama M., Fujita T. Retinoic acid-inducible gene i-inducible mir-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor. J Biol Chem 2011, 286:26210-26219.
39. Patel J.R., Jain A., Chou Y.Y., Baum A., Ha T., Garcia-Sastre A. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep 2013, 14:780-787.
40. Peisley A., Wu B., Yao H., Walz T., Hur S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell 2013, 51:573-583.
41. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., Chu F., Walz T., Hur S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
42. Jiang X., Kinch L.N., Brautigam C.A., Chen X., Du F., Grishin N.V., Chen Z.J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
43. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 ring-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
44. Oshiumi H., Miyashita M., Matsumoto M., Seya T. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog 2013, 9:e1003533.
45. Versteeg G.A., Rajsbaum R., Sanchez-Aparicio M.T., Maestre A.M., Valdiviezo J., Shi M., Inn K.S., Fernandez-Sesma A., Jung J., Garcia-Sastre A. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013, 38:384-398.
46. Munir M., Berg M. The multiple faces of protein kinase R in antiviral defense. Virulence 2013, 4:85-89.
47. Onomoto K., Jogi M., Yoo J.S., Narita R., Morimoto S., Takemura A., Sambhara S., Kawaguchi A., Osari S., Nagata K., Matsumiya T., et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLOS ONE 2012, 7:e43031.
48. Ng C.S., Jogi M., Yoo J.S., Onomoto K., Koike S., Iwasaki T., Yoneyama M., Kato H., Fujita T. Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J Virol 2013, 87:9511-9522.
49. Witteveldt J., Blundell R., Maarleveld J.J., McFadden N., Evans D.J., Simmonds P. The influence of viral RNA secondary structure on interactions with innate host cell defences. Nucleic Acids Res 2014, 42:3314-3329.
50. Yoo J.S., Takahasi K., Ng C.S., Ouda R., Onomoto K., Yoneyama M., Lai J.C., Lattmann S., Nagamine Y., Matsui T., Iwabuchi K., et al. DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation. PLoS Pathog 2014, 10:e1004012.
51. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza a viruses. J Gen Virol 2008, 89(Pt 10):2359-2376.
52. Gack M.U., Albrecht R.A., Urano T., Inn K.S., Huang I.C., Carnero E., Farzan M., Inoue S., Jung J.U., Garcia-Sastre A. Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5:439-449.
53. Santiago F.W., Covaleda L.M., Sanchez-Aparicio M.T., Silvas J.A., Diaz-Vizarreta A.C., Patel J.R., Popov V., Yu X.J., Garcia-Sastre A., Aguilar P.V. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol 2014, 88:4572-4585.
54. Motz C., Schuhmann K.M., Kirchhofer A., Moldt M., Witte G., Conzelmann K.K., Hopfner K.P. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 2013, 339:690-693.
55. Li X.D., Sun L., Seth R.B., Pineda G., Chen Z.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102:17717-17722.
56. Brzozka K., Finke S., Conzelmann K.K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 2005, 79:7673-7681.
57. Unterstab G., Ludwig S., Anton A., Planz O., Dauber B., Krappmann D., Heins G., Ehrhardt C., Wolff T. Viral targeting of the interferon-{beta}-inducing TRAF family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 2005, 102:13640-13645.
58. Wu X., Qi X., Qu B., Zhang Z., Liang M., Li C., Cardona C.J., Li D., Xing Z. Evasion of antiviral immunity through sequestering of TBK1/IKKepsilon/IRF3 into viral inclusion bodies. J Virol 2014, 88:3067-3076.
59. Khaperskyy D.A., Hatchette T.F., McCormick C: Influenza A. virus inhibits cytoplasmic stress granule formation. FASEB J 2012, 26:1629-1639.
60. Takeuchi K., Komatsu T., Kitagawa Y., Sada K., Gotoh B. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J Virol 2008, 82:10102-10110.
61. Boonyaratanakornkit J., Bartlett E., Schomacker H., Surman S., Akira S., Bae Y.S., Collins P., Murphy B., Schmidt A. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol 2011, 85:1495-1506.
62. Davis W.G., Bowzard J.B., Sharma S.D., Wiens M.E., Ranjan P., Gangappa S., Stuchlik O., Pohl J., Donis R.O., Katz J.M., et al. The 3' untranslated regions of influenza genomic sequences are 5'ppp-independent ligands for RIG-I. PLOS ONE 2012, 7:e32661.
63. Strahle L., Garcin D., Kolakofsky D. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virol 2006, 351:101-111.
64. Deddouche S., Goubau D., Rehwinkel J., Chakravarty P., Begum S., Maillard P.V., Borg A., Matthews N., Feng Q., van Kuppeveld F.J.M., et al. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. eLife 2014, 3:e01535.
65. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., Veitinger S., Jacob R., Devignot S., Kochs G., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
66. Samanta M., Iwakiri D., Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008, 27:4150-4160.
67. Satoshi I., Makoto T., Shinji O., Yuichiro N., Yoichi N., Yusuke Y. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84:372-379.